Selling Your Business? Axial Matches You With Pre-Vetted M&A Advisors

Expert guidance through your entire exit process.

Start Your Exit

Our advisors deliver 25% higher sale prices on average

Members (273 results)

ProNAi Therapeutics, Inc.

Corporation

    This member has no reported closed transactions.

ProNAi Therapeutics is a drug development company advancing targeted therapeutics for the treatment of patients with cancer. We are an ambitious oncology drug development company oriented towards registration and commercialization. We have a world-class management team with a proven track record of success in oncology drug development and we intend to build a broad and diverse pipeline of promising oncology assets against emerging targets on the leading edge of cancer biology.

Urban SDK

Corporation

    This member has no reported closed transactions.

Urban SDK is a business intelligence platform that provides data-driven optimization for the real world. We provide mobility intelligence for smarter cities. We combine emerging, connected and smart technologies to digitally transform public services and align policy with measurable indicators of well-being.We are focused on small to medium-sized acquisitions and partner with exceptional companies seeking the next stage of growth. Post-acquisition, we work closely with our portfolio companies to drive measurable value for all stakeholders. 

AMKY Physicians services LLC

Corporation

    This member has no reported closed transactions.

At AMKY Physicians, we are a staffing and recruiting company specializing in personalized healthcare staffing solutions. Our focus is on connecting physicians, physician assistants (PA), and nurse practitioners (NP) with rewarding locum tenens jobs across the USA. Our mission is to ensure that you find the best full-time and locum opportunities to suit your needs. With a commitment to excellence, we strive to provide top-notch staffing solutions in the healthcare industry. Our dedicated team works tirelessly to match healthcare professionals with the right positions, taking into account…

Applied Minerals, Inc. (OTCBB:AMNL)

Corporation

    This member has no reported closed transactions.

Applied Minerals is the leading producer of halloysite clay and advanced natural iron oxide solutions from its wholly-owned Dragon Mine property in Utah. Halloysite is aluminosilicate clay that forms naturally occurring nanotubes. In addition to serving the traditional halloysite markets for use in technical ceramics and catalytic applications, the Company has developed niche applications that benefit from the tubular morphology of its halloysite. These applications include carriers of active ingredients in paints,coatings and building materials, environmental remediation,agricultural…

Jeal consulting inc

Corporation

    This member has no reported closed transactions.

I’m an operator–owner acquiring my first platform in essential, service-heavy industries. I bring 25+ years leading complex procurement and operations transformations across multiple sectors, with a consistent record of delivering measurable cost, quality, and service improvements. Highlights include: board-approved digital procurement strategy at Walgreens (projected $400M+ savings), EMEA facilities services integration and scaling at JLL, a 52% cost improvement on a $24M logistics spend at Aggreko, and P&L leadership on a $1.3B public-sector program. I’m MCIPS-qualified and known…

Auritec Pharmaceuticals, Inc.

Corporation

    This member has no reported closed transactions.

Auritec Pharmaceuticals, Inc. is a research and development (R&D) company, specializing in innovative, extended release drug delivery systems. Auritec was founded by Thomas J. Smith, MD. Dr. Smith was previously Medical Director and Chairman at Control Delivery Systems, Inc. (CDS), where he was the co-founder and PI on key patents. CDS, now Psivida Inc. (NASDQ - PSDV), is a successful device company specializing in ophthalmic extended release therapies. Dr. Smith is joined on Auritec's management team by Gary Ransom, a seasoned international business executive, who focuses on strategy,…

Marsala Biotech, Inc.

Corporation

    This member has no reported closed transactions.

Marsala Biotech Inc. is an Oncology company developing new treatments for cancer. The Company's lead technology E10A, is being evaluated in head and neck cancer patients. Currently there are only 2 FDA approved drugs which have significant drawbacks. Phase III clinical trials of E10A are planned for 2013 in China and North America. In addition to a huge commercial potential, E10A would help address this significant unmet medical need.Marsala's lead product E10A has established potential to treat Head and Neck Cancer, which has a market potential of 3.2 billion USD. E10A also has synergistic…

Alexion Pharmaceuticals, Inc. (NasdaqGS:ALXN)

Corporation

    This member has no reported closed transactions.

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening rare diseases. Patients with these devastating diseases often have no effective treatment options, and they and their families suffer with little hope. Our goal is to deliver medical breakthroughs where none currently exist. We are driven because we know people's lives depend on our work.Our first commercial product is Soliris® (eculizumab), the world's first and only approved terminal complement inhibitor. Today, Soliris is approved in…

Cyclica Inc

Corporation

    This member has no reported closed transactions.

The biggest unmet medical need is to provide safe and efficacious drugs to the patient. However, the pharmaceutical industry is currently facing a litany of challenges, including but not limited to: 1) lead identification; 2) lead optimization & prioritization; 3) predicting side effects and toxicity; 4) meeting efficacy requirements; 5) maximizing patent life on the market; and 6) product rescue/repositioning. As a result, R&D success rates are falling, and R&D spending is not contributing to increased sales. According to research by Jack Scannell published in Nature, “...the number of new…

Cubist Pharmaceuticals Inc. (NasdaqGS:CBST)

Corporation

    This member has no reported closed transactions.

Cubist Pharmaceuticalsis a bio-pharmaceutical company focused on the research, commercial­ization and creation of pharmaceutical products that address unmet medical needs in the acute care environment.

The Lubrizol Corporation

Corporation

    This member has no reported closed transactions.

About LubrizolLubrizol may not be a household name, but chances are good that you'll find Lubrizol products throughout your home…your workplace…anywhere your day takes you. As a company, we strive to be an essential ingredient in our customer's success through collaboration, applied science and demonstrated value. By formulating complex chemicals at the molecular level, Lubrizol engineers and chemists develop additives, ingredients and compounds that amplify the quality and performance of other products while reducing their environmental impact. And those products cover a wide range of…

Quadras Group

Corporation

    This member has no reported closed transactions.

QUADRAS is a global provider of unique, enterprise-class Data Collection and Professional Service solutions, with a specialization in mobile data capture and RFID technologies. Our business solutions are focused on optimizing operations, reducing expenses, and improving business processes, and they have successfully been applied across a wide range of industries.As recognized leaders in the Data Collection, RFID, and EAM/IT Consulting fields, we stand behind our know-how, our recommendations, and our implementations - we will execute what we promise and help you attain your key performance…

Kona Deep

Corporation

    This member has no reported closed transactions.

One Liner Description: Kona Deep® - The ONLY all natural electrolyte water on this planet! Bottled at the source in Hawaii.Business Summary: We manufacture and bottle "Kona Deep®", a deep seawaterdrinking brand. Deep seawater has become the No.1 food export of Hawaii, havingsurpassed Macadamia Nuts and Coffee (combined) in 2007. In 2011, over $140,000,000in deep sea bottled drinking water was exported from the State of Hawaii. In 2012, KonaDeep® became the #1 top-selling deep seawater brand in the USA. Our plan is tobecome #1 in the global market by leveraging our status as the #1 brand in…

Camargo Pharmaceutical Services

Corporation

    This member has no reported closed transactions.

At Camargo Pharmaceutical Services, we are strategic thinkers and doers. Camargo is your full-service drug development partner specializing in the 505(b)(2) process — a holistic approach for developing products that offer differentiated benefits. Before development even begins, we help verify profit potential by working with your team to develop a comprehensive program and timeline complete with critical milestones and cost objectives. We manage every facet of the plan throughout your development continuum, from feasibility assessments, formulation and testing the drug product, to…

Natural Vitamins Laboratory

Corporation

    This member has no reported closed transactions.

Natural Vitamins Laboratories is an industry leading manufacturer of health and wellness care solutions. Our products include a comprehensive line of nutritional supplements, multi-vitamins, minerals, herbs Established in 1993, Natural Vitamins Laboratories is committed to provide you with the lifelong benefits of sound nutrition and wellness practices.

University of Michigan Tech Transfer Office

Corporation

    This member has no reported closed transactions.

U-M Tech Transfer is the University organization responsible for the transfer of University technology to the marketplace.Mission:To effectively transfer University technologies to the market so as to generate benefits for the University, the community and the general public.

Neurotez, Inc.

Corporation

    This member has no reported closed transactions.

Neurotez, Inc. is a private corporation whose primary goal is to develop a Leptin product as a novel hormone replacement therapy for Alzheimer's disease (AD) and/or as a preventative for those who are at risk.Leptin, a naturally occurring human hormone associated with various metabolic effects, has a large number of receptors in memory centers of the brain. This protein is often present at decreased levels in patients suffering from Alzheimer's disease, and cognitive deterioration in AD patients correlates strongly with a decline in circulating Leptin levels. The administration of Leptin…

Alpha Cancer Technologies

Corporation

    This member has no reported closed transactions.

Alpha Cancer Technologies Inc., (ACT) is a private clinical stage biotechnology company with products under development in oncology and auto-immune disease indications. The company’s drug products use our proprietary recombinant human alpha fetoprotein (AFP) with unique immuno-oncology properties.One of the largest US biotech companies recently purchased a 14% equity stake in ACT for US $7.5 million as part of a larger financing with institutional and private investors.

Spectrum Pharmaceuticals, Inc. (NasdaqGS:SPPI)

Corporation

    This member has no reported closed transactions.

Our primary strategy is comprised of acquiring, developing and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. In addition to building an efficient in-house clinical development organization with regulatory and data management capabilities, Spectrum has established a commercial infrastructure for itsmarketed products. We have two oncology products on the market, one for low-grade or follicular non-Hodgkin's lymphoma and one for advanced metastatic colorectal cancer, as well as two drugs in late stage development: apaziquone and belinostat, along…

Learn More About Joining Axial as a Member

Request Information

The M&A platform that works

Axial helps you find your perfect deal partner

Over 2,500 deals closed since 2010
Over $3B+ in volume

briefcase

Owners ($1M+ Net Profits)

Connect with pre-qualified advisors
in 1 week, not 4 months

add

Buyers

Source deals from 3,500+ advisors without expanding BD resources

megaphone

Advisors

Connect with 4,000+ buyers pre-qualified for your deal parameters

Complete the Form for Directory Access

Your information is safe and will never be shared or sold.

Interested in finding out how investors are using Axial to source deals? Request Information

Interested in connecting with strategic buyers, family offices and PE firms? Request Information

Connect with strategic buyers, family offices and PE firms Request Information

Join the Axial network to streamline your deal origination and buyer discovery process Request Information

Let us curate Relevant Introductions.

Rather than a one-off introduction to company, work with an Axial Exit Consultant to find the best options from our network of 2,500 M&A advisors — at no cost to you.

Companies sold using Axial Advisor Finder:

Get Introduced to the Right Advisors

This service is complimentary and all information is confidential. Looking to learn more? Complete the form above.

By providing telephone number and submitting the form you are consenting to be contacted by SMS text message. Message & data rates may apply. Reply STOP to opt of further messaging.

We've Received Your Request

A member of our team will follow up to coordinate next steps.

Explore Axial
Template